APG logo

APi Group (APG) Stock

Profile

Country:

United States

IPO:

29 April 2020

Indexes:

Not included

Description:

APG (APi Group) is a global leader in safety, security, and building services. They provide solutions in construction, maintenance, and management for various industries, ensuring efficient operations and enhanced safety. With a focus on innovation, APG supports clients in creating safe and sustainable environments.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Oct 31, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

05 Nov '24 Barclays
Overweight
01 Nov '24 RBC Capital
Sector Perform
05 Aug '24 Barclays
Overweight
02 Aug '24 JP Morgan
Neutral
02 Aug '24 Baird
Outperform
16 Apr '24 Baird
Outperform
08 Apr '24 RBC Capital
Sector Perform
08 Apr '24 Citigroup
Buy
15 Mar '24 Jefferies
Buy
06 Mar '24 JP Morgan
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

APi Group Announces CFO Transition
APi Group Announces CFO Transition
APi Group Announces CFO Transition
APG
businesswire.com22 November 2024

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today announced that Kevin Krumm, Chief Financial Officer, will step down from his role on December 13, 2024, to accept another opportunity. David Jackola, current Chief Financial Officer and Vice President of Transformation at APi International, will assume the role of interim Chief Financial Officer upon Krumm's departure and until a successor is appointed. Jackola is a seasoned senior finance exe.

Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis
Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis
Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis
APG
seekingalpha.com10 November 2024

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing and potential applications in asthma, COPD, and psoriasis. APGE's investigational pipeline includes APG808 and APG990, targeting different inflammatory pathways, enhancing its potential in the I&I market. APGE's strong cash runway and multiple upcoming catalysts, including Phase 2 results for APG777, justify its current valuation premium.

APi Group Corporation (APG) Q3 2024 Earnings Call Transcript
APi Group Corporation (APG) Q3 2024 Earnings Call Transcript
APi Group Corporation (APG) Q3 2024 Earnings Call Transcript
APG
seekingalpha.com01 November 2024

APi Group Corporation (NYSE:APG ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Adam Fee - VP, IR Russell Becker - President and CEO Kevin Krumm - EVP and CFO Conference Call Participants Kenyon Pelletier - Barclays Stephanie Moore - Jefferies Andy Wittmann - Baird Kathryn Thompson - Thompson Research Group Andy Kaplowitz - Citigroup Josh Chan - UBS Jon Tanwanteng - CJS Securities Operator Good morning, ladies and gentlemen and welcome to APi Group's Third Quarter 2024 Financial Results Conference Call. All participants are now in a listen-only mode until the question-and-answer session.

APi (APG) Meets Q3 Earnings Estimates
APi (APG) Meets Q3 Earnings Estimates
APi (APG) Meets Q3 Earnings Estimates
APG
zacks.com31 October 2024

APi (APG) came out with quarterly earnings of $0.51 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.48 per share a year ago.

Genuine Parts Company: Rating Downgrade On Weak Near-Term Outlook
Genuine Parts Company: Rating Downgrade On Weak Near-Term Outlook
Genuine Parts Company: Rating Downgrade On Weak Near-Term Outlook
APG
seekingalpha.com24 October 2024

I downgrade Genuine Parts Company stock from buy to hold due to poor 3Q24 performance and a weak macroeconomic outlook impacting both APG and IPG segments. 3Q24 results showed disappointing comparable sales growth, with APG and IPG segments underperforming, leading to a significant miss on EPS estimates. The outlook remains bleak, with no signs of improvement in consumer spending and industrial production.

APi (APG) Reports Next Week: Wall Street Expects Earnings Growth
APi (APG) Reports Next Week: Wall Street Expects Earnings Growth
APi (APG) Reports Next Week: Wall Street Expects Earnings Growth
APG
zacks.com24 October 2024

APi (APG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is the Options Market Predicting a Spike in APi Group (APG) Stock?
Is the Options Market Predicting a Spike in APi Group (APG) Stock?
Is the Options Market Predicting a Spike in APi Group (APG) Stock?
APG
zacks.com22 October 2024

Investors need to pay close attention to APi Group (APG) stock based on the movements in the options market lately.

APi Group Confirms Date of Third Quarter 2024 Earnings Release
APi Group Confirms Date of Third Quarter 2024 Earnings Release
APi Group Confirms Date of Third Quarter 2024 Earnings Release
APG
businesswire.com17 October 2024

NEW BRIGHTON, Minn.--(BUSINESS WIRE)--APi Group Corporation (NYSE: APG) (“APi”) announced today that it intends to release its financial results for the three and nine months ended September 30, 2024, before the market opens on Thursday, October 31, 2024. Third Quarter Earnings Conference Call APi will hold a webcast/dial-in conference call to discuss its financial results at 8:30 a.m. (Eastern Time) on Thursday, October 31, 2024. Participants on the call will include Russell A. Becker, Preside.

APi Price And Earnings Diverge, Setting Up Strong Buy Rating
APi Price And Earnings Diverge, Setting Up Strong Buy Rating
APi Price And Earnings Diverge, Setting Up Strong Buy Rating
APG
https://seekingalpha.com/article/4726768-api-price-and-earnings-diverge-setting-up-strong-buy-rating15 October 2024

APi Group Corporation's earnings are set to grow in Q3 and Q4 2024, despite a recent decline in share price, presenting a Strong Buy opportunity. The company's 13/60/80 framework aims to boost adjusted EBITDA margins, recurring revenue, and free cash flow conversion. APi's aggressive acquisition strategy, including the recent purchase of Elevated Facility Services Group, supports its growth and expansion goals.

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
APG
globenewswire.com19 August 2024

Interim safety and pharmacokinetic data from Phase 1 healthy volunteers trial anticipated in 2025 Initiation of the first clinical trial of APG777 and APG990 combination expected to commence in 2025 with the potential for greater efficacy in atopic dermatitis and across I&I diseases SAN FRANCISCO and WALTHAM, Mass., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD) and other I&I indications, today announced that it has initiated dosing of healthy volunteers in its first clinical trial for APG990, a novel, subcutaneous (SQ) half-life extended monoclonal antibody targeting OX40L, which is being developed initially as a treatment for people living with AD.

FAQ

  • What is the primary business of APi Group?
  • What is the ticker symbol for APi Group?
  • Does APi Group pay dividends?
  • What sector is APi Group in?
  • What industry is APi Group in?
  • What country is APi Group based in?
  • When did APi Group go public?
  • Is APi Group in the S&P 500?
  • Is APi Group in the NASDAQ 100?
  • Is APi Group in the Dow Jones?
  • When was APi Group's last earnings report?
  • When does APi Group report earnings?
  • Should I buy APi Group stock now?

What is the primary business of APi Group?

APG (APi Group) is a global leader in safety, security, and building services. They provide solutions in construction, maintenance, and management for various industries, ensuring efficient operations and enhanced safety. With a focus on innovation, APG supports clients in creating safe and sustainable environments.

What is the ticker symbol for APi Group?

The ticker symbol for APi Group is NYSE:APG

Does APi Group pay dividends?

No, APi Group does not pay dividends

What sector is APi Group in?

APi Group is in the Industrials sector

What industry is APi Group in?

APi Group is in the Engineering & Construction industry

What country is APi Group based in?

APi Group is headquartered in United States

When did APi Group go public?

APi Group's initial public offering (IPO) was on 29 April 2020

Is APi Group in the S&P 500?

No, APi Group is not included in the S&P 500 index

Is APi Group in the NASDAQ 100?

No, APi Group is not included in the NASDAQ 100 index

Is APi Group in the Dow Jones?

No, APi Group is not included in the Dow Jones index

When was APi Group's last earnings report?

APi Group's most recent earnings report was on 31 October 2024

When does APi Group report earnings?

The next expected earnings date for APi Group is 28 February 2025

Should I buy APi Group stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions